Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol vs TIVA for Pulsed-field Ablation in AF
NCT06013345Phase 3Completed
- Sponsor
- Charles University
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in Atrial fibrillation (AFib), sponsored by Charles University. Started Oct 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06013345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013345.